Paper577380
Modification of the classification of the eye changes of Graves' disease.
Werner SC. Am J Ophthalmol, 1977. Cited by 196 papers, by iCite.
Cite this record
ConductScience Library. Modification of the classification of the eye changes of Graves' disease. Papers, record 577380. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/577380
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics4
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Eye Diseases | Major topic |
| Graves Disease | Major topic |
| Humans | |
| Terminology as Topic |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT00348413 | Thyroid Treatment Trial | Background |
Source ClinicalTrials.gov
Cited by68
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 196 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41649397 | Approach to the patient: therapeutic mitigation of lacrimal manifestations in thyroid eye disease. | J Clin Endocrinol Metab | 2026 | https://conductscience.org/library/papers/41649397 | PubMed |
| 41297932 | Impacts of physical, metabolic, and immunological factors on the exophthalmometry values of a contemporary Japanese population with/without Graves' disease. | Endocr J | 2026 | https://conductscience.org/library/papers/41297932 | PubMed |
| 41059227 | Clinical profiling of TPOAb and TGAb in patients with thyrotrophin receptor antibody-negative thyroid eye disease: A single-center observational study in China. | Front Endocrinol (Lausanne) | 2025 | https://conductscience.org/library/papers/41059227 | PubMed |
| 40888942 | Pediatric graves' orbitopathy: a case series of 136 Chinese patients. | Int Ophthalmol | 2025 | https://conductscience.org/library/papers/40888942 | PubMed |
| 40764083 | Association between initial lipid and lipoprotein levels, oxidative stress indicators and clinical efficacy of intravenous methylprednisolone in moderate-to-severe thyroid-associated ophthalmopathy: protocol for a real-world prospective cohort study. | BMJ Open | 2025 | https://conductscience.org/library/papers/40764083 | PubMed |
| 38983053 | The association of race with thyroid eye disease presentation and outcomes. | Front Ophthalmol (Lausanne) | 2023 | https://conductscience.org/library/papers/38983053 | PubMed |
| 38804861 | The circulating IL-35+ regulatory B cells are associated with thyroid associated opthalmopathy. | Immun Inflamm Dis | 2024 | https://conductscience.org/library/papers/38804861 | PubMed |
| 38728262 | Single-cell BCR and transcriptome analysis reveals peripheral immune signatures in patients with thyroid-associated ophthalmopathy. | Aging (Albany NY) | 2024 | https://conductscience.org/library/papers/38728262 | PubMed |
| 37606076 | Circulating miR-146a predicts glucocorticoid response in thyroid eye disease. | Eur Thyroid J | 2023 | https://conductscience.org/library/papers/37606076 | PubMed |
| 37060084 | Efficacy of selenium supplementation for mild-to-moderate Graves' ophthalmopathy in a selenium-sufficient area (SeGOSS trial): study protocol for a phase III, multicenter, open-label, randomized, controlled intervention trial. | Trials | 2023 | https://conductscience.org/library/papers/37060084 | PubMed |
| 36539754 | Analysis of macular blood flow changes in thyroid associated ophthalmopathy. | BMC Ophthalmol | 2022 | https://conductscience.org/library/papers/36539754 | PubMed |
| 36185985 | The Effect of Thyroid Eye Disease on Corneal Biomechanical Properties. | Beyoglu Eye J | 2022 | https://conductscience.org/library/papers/36185985 | PubMed |
| 35791115 | Update on thyroid eye disease: Regional variations in prevalence, diagnosis, and management. | Indian J Ophthalmol | 2022 | https://conductscience.org/library/papers/35791115 | PubMed |
| 35551579 | Thicknesses of the retinal layers in patients with Graves' disease with or without orbitopathy. | Int Ophthalmol | 2022 | https://conductscience.org/library/papers/35551579 | PubMed |
| 35309667 | RAPD as a clinical alert for early evidence of dysthyroid optic neuropathy. | J Family Med Prim Care | 2022 | https://conductscience.org/library/papers/35309667 | PubMed |
| 34637060 | Altered peripapillary vessel density and nerve fiber layer thickness in thyroid-associated ophthalmopathy using optical coherence tomography angiography. | Int Ophthalmol | 2022 | https://conductscience.org/library/papers/34637060 | PubMed |
| 33899194 | Graves' Orbitopathy: Report of 82 cases. | Tunis Med | 2021 | https://conductscience.org/library/papers/33899194 | PubMed |
| 33564472 | The Clinical Features of Graves' Orbitopathy with Elevated Intraocular Pressure. | J Ophthalmol | 2021 | https://conductscience.org/library/papers/33564472 | PubMed |
| 33374706 | Current Knowledge on Graves' Orbitopathy. | J Clin Med | 2020 | https://conductscience.org/library/papers/33374706 | PubMed |
| 32681301 | [Orbital decompression in Graves' orbitopathy-Experiences and results]. | Ophthalmologe | 2021 | https://conductscience.org/library/papers/32681301 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/577380
GET https://conductscience.org/api/papers/v1/577380/cited_by?page=2